美国联邦政府将各州许可的医用大麻重新归类为附表三,可能会减轻Tilray Brands等运营商的科研和税收负担,而更广泛的重新分类听证会定于6月举行。
美国联邦政府将各州许可的医用大麻重新归类为附表三,可能会减轻Tilray Brands等运营商的科研和税收负担,而更广泛的重新分类听证会定于6月举行。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.